Clinical Trials Directory

Trials / Completed

CompletedNCT06889116

VExUS Score and AKI in Critically Ill Adult patients-a Prospective Observational Study.

Correlation of Point of Care Venous Excess Ultrasonography (VExUS) Score and Acute Kidney Injury (AKI) in Critically Ill Adult Patients- a Prospective Observational Study.

Status
Completed
Phase
Study type
Observational
Enrollment
52 (actual)
Sponsor
Tribhuvan University Teaching Hospital, Institute Of Medicine. · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Introduction Renal perfusion is dependent on the renal perfusion pressure across the renal capillaries. Venous congestion due to excess fluid therapy can drastically reduce the renal perfusion pressure in spite of a normal mean arterial pressure. Increasing cumulative fluid balance during the ICU stay has been found to be associated with negative outcomes including acute kidney injury (AKI) and hospital mortality. Venous excess ultrasound (VExUS) to assess the Doppler studies of renal, hepatic and portal veins along with the inferior venacava has been shown to reliably predict the incidence of AKI in certain ICU patient population more specifically in cardiorenal syndrome. The aim of this study was to correlate the incidence of AKI and VExUS scores in a mixed ICU population and hence determine the contribution of venous congestion on the causation of AKI in a general ICU. Methods: The patients included who have AKI at admission or developed AKI during their ICU stay were included. The definition of AKI used for this study was as defined by Kidney Disease: Improving Global Outcomes (KDIGO). Point of care VExUS scans were done on each patient at inclusion (day 0), then each day for a total of 4 days (day 1, 2 and 3), till initiation of renal replacement therapy, death or discharge form the ICU. Correlation between VExUS grades and creatinine clearances was explored as the primary objective.

Conditions

Timeline

Start date
2023-05-15
Primary completion
2024-01-07
Completion
2024-01-11
First posted
2025-03-21
Last updated
2025-03-21

Locations

1 site across 1 country: Nepal

Source: ClinicalTrials.gov record NCT06889116. Inclusion in this directory is not an endorsement.